2018年全球常规疫苗接种覆盖率
世界卫生大会2012年批准的《2011-2020年全球疫苗行动计划》呼吁所有国家到2020年实现本国免疫规划中所有疫苗的国家覆盖率≥90%。本报告基于世界卫生组织(WHO)和联合国儿童基金会(UNICEF)2018年全球疫苗接种覆盖率估计值,呈现全球、区域和国家疫苗接种覆盖率估计及趋势,包括脱漏率。全球DTP1覆盖率从2010年89%至2018年90%相对未变,DTP3从2010年84%至2018年86%相对一致。
要点
- 全球DTP1覆盖率从2010年89%至2018年90%相对未变,DTP3从2010年84%至2018年86%相对一致。
- DTP1至DTP3脱漏率全球从2010年6%降至2018年4%。
核心结论
- 为实现儿童期、青少年期和成年期推荐疫苗的全球接种覆盖率目标,需要针对当地未完成接种的决定因素制定量身定制的策略,包括针对难以触及和难以接种的人群。
研究设计与样本
- 本报告基于WHO和UNICEF截至2018年的全球疫苗接种覆盖率估计值,呈现全球、区域和国家疫苗接种覆盖率估计及趋势,包括脱漏率。
主要发现
- 全球DTP1覆盖率从2010年89%至2018年90%相对未变;DTP3覆盖率从2010年84%至2018年86%相对一致。
- DTP1至DTP3脱漏率全球从2010年6%降至2018年4%。
- MCV1全球覆盖率在2010-2018年间保持在84%至86%之间。
- 在第二年开始提供MCV2的国家,覆盖率从2007年19%增至2018年54%;在较年长年龄组(3-14岁儿童)提供MCV2的国家,覆盖率从2007年36%增至2018年69%。
关键数值与推荐
- 《2011-2020年全球疫苗行动计划》呼吁所有国家到2020年实现本国免疫规划中所有疫苗的国家覆盖率≥90%。
- 2018年全球MCV1和MCV2覆盖率估计差异为17%。
临床怎么用
- 为实现全球疫苗接种覆盖率目标,需要针对当地未完成接种的决定因素制定量身定制的策略,包括针对难以触及和难以接种的人群。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (GVAP) (1) calls on all countries to reach ≥90% national coverage with all vaccines in the country's national immunization schedule by 2020. Building on previous analyses (2) and using the World Health Organization (WHO) and United Nations Children's Fund (UNICEF) global vaccination coverage estimates as of 2018, this report presents global, regional, and national vaccination coverage estimates and trends, including vaccination dropout rates. According to these estimates, global coverage with the first dose of diphtheria and tetanus toxoids and pertussis-containing vaccine (DTP1) remained relatively unchanged from 2010 (89%) to 2018 (90%). Global coverage with the third DTP dose (DTP3) followed a similar global trend to that of DTP1, remaining relatively consistent from 2010 (84%) to 2018 (86%) (3). Globally, 19.4 million children (14%) were not fully vaccinated in 2018, and among them, 13.5 million (70%) did not receive any DTP doses. Overall, dropout rates from DTP1 to DTP3 decreased globally from 6% in 2010 to 4% in 2018. Global coverage with the first dose of measles-containing vaccine (MCV1) remained between 84% and 86% during 2010-2018. Among countries that offer a second MCV dose (MCV2) during the second year of life, coverage increased from 19% in 2007 to 54% in 2018; among countries offering MCV2 to older age groups (children aged 3-14 years), coverage also increased, from 36% in 2007 to 69% in 2018 (3). Globally, the estimated difference in coverage with MCV1 and MCV2 in 2018 was 17%. However, among new and underused vaccines, global coverage increased from 2007 to 2018 for completed series of rotavirus vaccine, pneumococcal conjugate vaccine (PCV), rubella vaccine, Haemophilus influenzae type b vaccine (Hib), and hepatitis B vaccine (HepB). To reach global vaccination coverage goals for vaccines recommended during childhood, adolescence, and adulthood, tailored strategies that address local determinants for incomplete vaccination are needed, including targeting hard-to-reach and hard-to-vaccinate populations.
引用
- Peck M, Gacic-Dobo M, Diallo MS, et al. Global Routine Vaccination Coverage, 2018. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31647786. doi:10.15585/mmwr.mm6842a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。